nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—ABCB1—esophageal cancer	0.684	1	CbGaD
Buspirone—Temperature intolerance—Capecitabine—esophageal cancer	0.00853	0.0519	CcSEcCtD
Buspirone—Slurred speech—Cisplatin—esophageal cancer	0.00425	0.0258	CcSEcCtD
Buspirone—Cardiomyopathy—Capecitabine—esophageal cancer	0.00274	0.0166	CcSEcCtD
Buspirone—Neck stiffness—Methotrexate—esophageal cancer	0.00219	0.0133	CcSEcCtD
Buspirone—Nail disorder—Capecitabine—esophageal cancer	0.00216	0.0131	CcSEcCtD
Buspirone—Nuchal rigidity—Methotrexate—esophageal cancer	0.00201	0.0122	CcSEcCtD
Buspirone—Dysarthria—Cisplatin—esophageal cancer	0.00201	0.0122	CcSEcCtD
Buspirone—Pain—Carboplatin—esophageal cancer	0.00198	0.012	CcSEcCtD
Buspirone—Metrorrhagia—Capecitabine—esophageal cancer	0.00196	0.0119	CcSEcCtD
Buspirone—Throat sore—Capecitabine—esophageal cancer	0.00194	0.0118	CcSEcCtD
Buspirone—Blister—Capecitabine—esophageal cancer	0.00194	0.0118	CcSEcCtD
Buspirone—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.00193	0.0117	CcSEcCtD
Buspirone—Hiccups—Cisplatin—esophageal cancer	0.0019	0.0115	CcSEcCtD
Buspirone—Body temperature increased—Carboplatin—esophageal cancer	0.00183	0.0111	CcSEcCtD
Buspirone—Tingling sensation—Capecitabine—esophageal cancer	0.00174	0.0106	CcSEcCtD
Buspirone—Nail disorder—Methotrexate—esophageal cancer	0.00161	0.00977	CcSEcCtD
Buspirone—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.00156	0.00949	CcSEcCtD
Buspirone—Rectal haemorrhage—Capecitabine—esophageal cancer	0.00155	0.00942	CcSEcCtD
Buspirone—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00154	0.00936	CcSEcCtD
Buspirone—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00152	0.00924	CcSEcCtD
Buspirone—Nasal congestion—Cisplatin—esophageal cancer	0.00151	0.0092	CcSEcCtD
Buspirone—Nocturia—Capecitabine—esophageal cancer	0.00151	0.00917	CcSEcCtD
Buspirone—Dysarthria—Capecitabine—esophageal cancer	0.00148	0.009	CcSEcCtD
Buspirone—Coordination abnormal—Capecitabine—esophageal cancer	0.00143	0.00867	CcSEcCtD
Buspirone—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00141	0.00855	CcSEcCtD
Buspirone—Hiccups—Capecitabine—esophageal cancer	0.0014	0.00851	CcSEcCtD
Buspirone—Stupor—Methotrexate—esophageal cancer	0.0014	0.00849	CcSEcCtD
Buspirone—Influenza like illness—Capecitabine—esophageal cancer	0.00136	0.00826	CcSEcCtD
Buspirone—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00135	0.00822	CcSEcCtD
Buspirone—Face oedema—Cisplatin—esophageal cancer	0.00133	0.00809	CcSEcCtD
Buspirone—Ecchymosis—Capecitabine—esophageal cancer	0.00127	0.00769	CcSEcCtD
Buspirone—Cramp muscle—Cisplatin—esophageal cancer	0.00124	0.00755	CcSEcCtD
Buspirone—Mental disability—Capecitabine—esophageal cancer	0.00122	0.00739	CcSEcCtD
Buspirone—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00116	0.00706	CcSEcCtD
Buspirone—Eye pain—Capecitabine—esophageal cancer	0.00113	0.00684	CcSEcCtD
Buspirone—Dysarthria—Methotrexate—esophageal cancer	0.0011	0.0067	CcSEcCtD
Buspirone—Increased appetite—Capecitabine—esophageal cancer	0.00108	0.00658	CcSEcCtD
Buspirone—Dermatitis bullous—Capecitabine—esophageal cancer	0.00106	0.00646	CcSEcCtD
Buspirone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00105	0.00637	CcSEcCtD
Buspirone—Myocardial infarction—Cisplatin—esophageal cancer	0.00104	0.00633	CcSEcCtD
Buspirone—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00104	0.0063	CcSEcCtD
Buspirone—Conjunctivitis—Cisplatin—esophageal cancer	0.00103	0.00628	CcSEcCtD
Buspirone—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00101	0.00613	CcSEcCtD
Buspirone—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00101	0.00612	CcSEcCtD
Buspirone—Face oedema—Capecitabine—esophageal cancer	0.000982	0.00596	CcSEcCtD
Buspirone—Bradycardia—Cisplatin—esophageal cancer	0.000971	0.0059	CcSEcCtD
Buspirone—Urinary retention—Capecitabine—esophageal cancer	0.000967	0.00587	CcSEcCtD
Buspirone—Mood swings—Capecitabine—esophageal cancer	0.000963	0.00585	CcSEcCtD
Buspirone—Ataxia—Capecitabine—esophageal cancer	0.000956	0.00581	CcSEcCtD
Buspirone—Ecchymosis—Methotrexate—esophageal cancer	0.000943	0.00573	CcSEcCtD
Buspirone—Dry skin—Capecitabine—esophageal cancer	0.000932	0.00566	CcSEcCtD
Buspirone—Muscular weakness—Capecitabine—esophageal cancer	0.000897	0.00545	CcSEcCtD
Buspirone—Tinnitus—Cisplatin—esophageal cancer	0.00089	0.00541	CcSEcCtD
Buspirone—Flushing—Cisplatin—esophageal cancer	0.000886	0.00538	CcSEcCtD
Buspirone—Alopecia—Cisplatin—esophageal cancer	0.000843	0.00512	CcSEcCtD
Buspirone—Erythema—Cisplatin—esophageal cancer	0.000831	0.00505	CcSEcCtD
Buspirone—Dysuria—Capecitabine—esophageal cancer	0.000822	0.00499	CcSEcCtD
Buspirone—Flatulence—Cisplatin—esophageal cancer	0.000819	0.00497	CcSEcCtD
Buspirone—Weight increased—Capecitabine—esophageal cancer	0.0008	0.00486	CcSEcCtD
Buspirone—Muscle spasms—Cisplatin—esophageal cancer	0.000799	0.00485	CcSEcCtD
Buspirone—Weight decreased—Capecitabine—esophageal cancer	0.000795	0.00483	CcSEcCtD
Buspirone—Vision blurred—Cisplatin—esophageal cancer	0.000783	0.00476	CcSEcCtD
Buspirone—Depression—Capecitabine—esophageal cancer	0.000781	0.00475	CcSEcCtD
Buspirone—Tremor—Cisplatin—esophageal cancer	0.000778	0.00473	CcSEcCtD
Buspirone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000772	0.00469	CcSEcCtD
Buspirone—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000772	0.00469	CcSEcCtD
Buspirone—Ill-defined disorder—Cisplatin—esophageal cancer	0.000771	0.00468	CcSEcCtD
Buspirone—Myocardial infarction—Capecitabine—esophageal cancer	0.000768	0.00467	CcSEcCtD
Buspirone—Conjunctivitis—Capecitabine—esophageal cancer	0.000762	0.00463	CcSEcCtD
Buspirone—Malaise—Cisplatin—esophageal cancer	0.000749	0.00455	CcSEcCtD
Buspirone—Leukopenia—Cisplatin—esophageal cancer	0.000744	0.00452	CcSEcCtD
Buspirone—Epistaxis—Capecitabine—esophageal cancer	0.000739	0.00449	CcSEcCtD
Buspirone—Convulsion—Cisplatin—esophageal cancer	0.00072	0.00437	CcSEcCtD
Buspirone—Mood swings—Methotrexate—esophageal cancer	0.000717	0.00436	CcSEcCtD
Buspirone—Bradycardia—Capecitabine—esophageal cancer	0.000716	0.00435	CcSEcCtD
Buspirone—Ataxia—Methotrexate—esophageal cancer	0.000712	0.00432	CcSEcCtD
Buspirone—Myalgia—Cisplatin—esophageal cancer	0.000707	0.0043	CcSEcCtD
Buspirone—Haemoglobin—Capecitabine—esophageal cancer	0.000707	0.0043	CcSEcCtD
Buspirone—Haemorrhage—Capecitabine—esophageal cancer	0.000703	0.00427	CcSEcCtD
Buspirone—Hypoaesthesia—Capecitabine—esophageal cancer	0.0007	0.00425	CcSEcCtD
Buspirone—Discomfort—Cisplatin—esophageal cancer	0.000699	0.00425	CcSEcCtD
Buspirone—Oedema—Cisplatin—esophageal cancer	0.000678	0.00412	CcSEcCtD
Buspirone—Thrombocytopenia—Cisplatin—esophageal cancer	0.000664	0.00403	CcSEcCtD
Buspirone—Tachycardia—Cisplatin—esophageal cancer	0.000662	0.00402	CcSEcCtD
Buspirone—Tinnitus—Capecitabine—esophageal cancer	0.000656	0.00398	CcSEcCtD
Buspirone—Hyperhidrosis—Cisplatin—esophageal cancer	0.000655	0.00398	CcSEcCtD
Buspirone—Flushing—Capecitabine—esophageal cancer	0.000653	0.00397	CcSEcCtD
Buspirone—Eosinophilia—Methotrexate—esophageal cancer	0.000648	0.00394	CcSEcCtD
Buspirone—Anorexia—Cisplatin—esophageal cancer	0.000646	0.00393	CcSEcCtD
Buspirone—Hypotension—Cisplatin—esophageal cancer	0.000634	0.00385	CcSEcCtD
Buspirone—Chills—Capecitabine—esophageal cancer	0.000631	0.00383	CcSEcCtD
Buspirone—Alopecia—Capecitabine—esophageal cancer	0.000622	0.00378	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000618	0.00375	CcSEcCtD
Buspirone—Erythema—Capecitabine—esophageal cancer	0.000612	0.00372	CcSEcCtD
Buspirone—Dysuria—Methotrexate—esophageal cancer	0.000612	0.00372	CcSEcCtD
Buspirone—Paraesthesia—Cisplatin—esophageal cancer	0.000609	0.0037	CcSEcCtD
Buspirone—Dyspnoea—Cisplatin—esophageal cancer	0.000604	0.00367	CcSEcCtD
Buspirone—Flatulence—Capecitabine—esophageal cancer	0.000603	0.00367	CcSEcCtD
Buspirone—Erectile dysfunction—Methotrexate—esophageal cancer	0.000603	0.00366	CcSEcCtD
Buspirone—Dysgeusia—Capecitabine—esophageal cancer	0.0006	0.00364	CcSEcCtD
Buspirone—Decreased appetite—Cisplatin—esophageal cancer	0.000589	0.00358	CcSEcCtD
Buspirone—Muscle spasms—Capecitabine—esophageal cancer	0.000589	0.00358	CcSEcCtD
Buspirone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000585	0.00356	CcSEcCtD
Buspirone—Drowsiness—Methotrexate—esophageal cancer	0.000583	0.00354	CcSEcCtD
Buspirone—Depression—Methotrexate—esophageal cancer	0.000582	0.00353	CcSEcCtD
Buspirone—Pain—Cisplatin—esophageal cancer	0.00058	0.00352	CcSEcCtD
Buspirone—Vision blurred—Capecitabine—esophageal cancer	0.000577	0.00351	CcSEcCtD
Buspirone—Tremor—Capecitabine—esophageal cancer	0.000574	0.00349	CcSEcCtD
Buspirone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000568	0.00345	CcSEcCtD
Buspirone—Conjunctivitis—Methotrexate—esophageal cancer	0.000567	0.00344	CcSEcCtD
Buspirone—Sweating—Methotrexate—esophageal cancer	0.000559	0.0034	CcSEcCtD
Buspirone—Feeling abnormal—Cisplatin—esophageal cancer	0.000559	0.00339	CcSEcCtD
Buspirone—Malaise—Capecitabine—esophageal cancer	0.000552	0.00335	CcSEcCtD
Buspirone—Epistaxis—Methotrexate—esophageal cancer	0.00055	0.00334	CcSEcCtD
Buspirone—Vertigo—Capecitabine—esophageal cancer	0.00055	0.00334	CcSEcCtD
Buspirone—Syncope—Capecitabine—esophageal cancer	0.000549	0.00334	CcSEcCtD
Buspirone—Leukopenia—Capecitabine—esophageal cancer	0.000548	0.00333	CcSEcCtD
Buspirone—Palpitations—Capecitabine—esophageal cancer	0.000541	0.00329	CcSEcCtD
Buspirone—Loss of consciousness—Capecitabine—esophageal cancer	0.000538	0.00327	CcSEcCtD
Buspirone—Body temperature increased—Cisplatin—esophageal cancer	0.000536	0.00326	CcSEcCtD
Buspirone—Hypertension—Capecitabine—esophageal cancer	0.000529	0.00321	CcSEcCtD
Buspirone—Haemoglobin—Methotrexate—esophageal cancer	0.000526	0.0032	CcSEcCtD
Buspirone—Haemorrhage—Methotrexate—esophageal cancer	0.000524	0.00318	CcSEcCtD
Buspirone—Arthralgia—Capecitabine—esophageal cancer	0.000521	0.00317	CcSEcCtD
Buspirone—Myalgia—Capecitabine—esophageal cancer	0.000521	0.00317	CcSEcCtD
Buspirone—Chest pain—Capecitabine—esophageal cancer	0.000521	0.00317	CcSEcCtD
Buspirone—Discomfort—Capecitabine—esophageal cancer	0.000515	0.00313	CcSEcCtD
Buspirone—Dry mouth—Capecitabine—esophageal cancer	0.00051	0.0031	CcSEcCtD
Buspirone—Confusional state—Capecitabine—esophageal cancer	0.000504	0.00306	CcSEcCtD
Buspirone—Oedema—Capecitabine—esophageal cancer	0.0005	0.00304	CcSEcCtD
Buspirone—Hypersensitivity—Cisplatin—esophageal cancer	0.000499	0.00303	CcSEcCtD
Buspirone—Shock—Capecitabine—esophageal cancer	0.000492	0.00299	CcSEcCtD
Buspirone—Thrombocytopenia—Capecitabine—esophageal cancer	0.000489	0.00297	CcSEcCtD
Buspirone—Tinnitus—Methotrexate—esophageal cancer	0.000488	0.00297	CcSEcCtD
Buspirone—Tachycardia—Capecitabine—esophageal cancer	0.000488	0.00296	CcSEcCtD
Buspirone—Asthenia—Cisplatin—esophageal cancer	0.000486	0.00296	CcSEcCtD
Buspirone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000483	0.00294	CcSEcCtD
Buspirone—Anorexia—Capecitabine—esophageal cancer	0.000476	0.00289	CcSEcCtD
Buspirone—Chills—Methotrexate—esophageal cancer	0.00047	0.00285	CcSEcCtD
Buspirone—Hypotension—Capecitabine—esophageal cancer	0.000467	0.00284	CcSEcCtD
Buspirone—Diarrhoea—Cisplatin—esophageal cancer	0.000464	0.00282	CcSEcCtD
Buspirone—Alopecia—Methotrexate—esophageal cancer	0.000463	0.00281	CcSEcCtD
Buspirone—Erythema—Methotrexate—esophageal cancer	0.000456	0.00277	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000455	0.00277	CcSEcCtD
Buspirone—Insomnia—Capecitabine—esophageal cancer	0.000452	0.00275	CcSEcCtD
Buspirone—Paraesthesia—Capecitabine—esophageal cancer	0.000449	0.00273	CcSEcCtD
Buspirone—Dysgeusia—Methotrexate—esophageal cancer	0.000446	0.00271	CcSEcCtD
Buspirone—Dyspnoea—Capecitabine—esophageal cancer	0.000446	0.00271	CcSEcCtD
Buspirone—Dyspepsia—Capecitabine—esophageal cancer	0.00044	0.00267	CcSEcCtD
Buspirone—Decreased appetite—Capecitabine—esophageal cancer	0.000434	0.00264	CcSEcCtD
Buspirone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000431	0.00262	CcSEcCtD
Buspirone—Vomiting—Cisplatin—esophageal cancer	0.000431	0.00262	CcSEcCtD
Buspirone—Fatigue—Capecitabine—esophageal cancer	0.000431	0.00262	CcSEcCtD
Buspirone—Vision blurred—Methotrexate—esophageal cancer	0.00043	0.00261	CcSEcCtD
Buspirone—Rash—Cisplatin—esophageal cancer	0.000427	0.0026	CcSEcCtD
Buspirone—Constipation—Capecitabine—esophageal cancer	0.000427	0.0026	CcSEcCtD
Buspirone—Pain—Capecitabine—esophageal cancer	0.000427	0.0026	CcSEcCtD
Buspirone—Dermatitis—Cisplatin—esophageal cancer	0.000427	0.00259	CcSEcCtD
Buspirone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000423	0.00257	CcSEcCtD
Buspirone—Feeling abnormal—Capecitabine—esophageal cancer	0.000412	0.0025	CcSEcCtD
Buspirone—Malaise—Methotrexate—esophageal cancer	0.000411	0.0025	CcSEcCtD
Buspirone—Vertigo—Methotrexate—esophageal cancer	0.00041	0.00249	CcSEcCtD
Buspirone—Leukopenia—Methotrexate—esophageal cancer	0.000408	0.00248	CcSEcCtD
Buspirone—Nausea—Cisplatin—esophageal cancer	0.000403	0.00245	CcSEcCtD
Buspirone—Urticaria—Capecitabine—esophageal cancer	0.000397	0.00241	CcSEcCtD
Buspirone—Body temperature increased—Capecitabine—esophageal cancer	0.000395	0.0024	CcSEcCtD
Buspirone—Convulsion—Methotrexate—esophageal cancer	0.000395	0.0024	CcSEcCtD
Buspirone—Myalgia—Methotrexate—esophageal cancer	0.000388	0.00236	CcSEcCtD
Buspirone—Chest pain—Methotrexate—esophageal cancer	0.000388	0.00236	CcSEcCtD
Buspirone—Arthralgia—Methotrexate—esophageal cancer	0.000388	0.00236	CcSEcCtD
Buspirone—Discomfort—Methotrexate—esophageal cancer	0.000383	0.00233	CcSEcCtD
Buspirone—Confusional state—Methotrexate—esophageal cancer	0.000375	0.00228	CcSEcCtD
Buspirone—Hypersensitivity—Capecitabine—esophageal cancer	0.000368	0.00224	CcSEcCtD
Buspirone—Thrombocytopenia—Methotrexate—esophageal cancer	0.000364	0.00221	CcSEcCtD
Buspirone—Hyperhidrosis—Methotrexate—esophageal cancer	0.00036	0.00219	CcSEcCtD
Buspirone—Asthenia—Capecitabine—esophageal cancer	0.000359	0.00218	CcSEcCtD
Buspirone—Anorexia—Methotrexate—esophageal cancer	0.000355	0.00215	CcSEcCtD
Buspirone—Pruritus—Capecitabine—esophageal cancer	0.000354	0.00215	CcSEcCtD
Buspirone—Hypotension—Methotrexate—esophageal cancer	0.000348	0.00211	CcSEcCtD
Buspirone—Diarrhoea—Capecitabine—esophageal cancer	0.000342	0.00208	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000339	0.00206	CcSEcCtD
Buspirone—Insomnia—Methotrexate—esophageal cancer	0.000336	0.00204	CcSEcCtD
Buspirone—Paraesthesia—Methotrexate—esophageal cancer	0.000334	0.00203	CcSEcCtD
Buspirone—Dyspnoea—Methotrexate—esophageal cancer	0.000332	0.00202	CcSEcCtD
Buspirone—Somnolence—Methotrexate—esophageal cancer	0.000331	0.00201	CcSEcCtD
Buspirone—Dizziness—Capecitabine—esophageal cancer	0.00033	0.00201	CcSEcCtD
Buspirone—Dyspepsia—Methotrexate—esophageal cancer	0.000327	0.00199	CcSEcCtD
Buspirone—Decreased appetite—Methotrexate—esophageal cancer	0.000323	0.00196	CcSEcCtD
Buspirone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000321	0.00195	CcSEcCtD
Buspirone—Fatigue—Methotrexate—esophageal cancer	0.000321	0.00195	CcSEcCtD
Buspirone—Pain—Methotrexate—esophageal cancer	0.000318	0.00193	CcSEcCtD
Buspirone—Vomiting—Capecitabine—esophageal cancer	0.000318	0.00193	CcSEcCtD
Buspirone—Rash—Capecitabine—esophageal cancer	0.000315	0.00191	CcSEcCtD
Buspirone—Dermatitis—Capecitabine—esophageal cancer	0.000315	0.00191	CcSEcCtD
Buspirone—Headache—Capecitabine—esophageal cancer	0.000313	0.0019	CcSEcCtD
Buspirone—Feeling abnormal—Methotrexate—esophageal cancer	0.000307	0.00186	CcSEcCtD
Buspirone—Nausea—Capecitabine—esophageal cancer	0.000297	0.0018	CcSEcCtD
Buspirone—Urticaria—Methotrexate—esophageal cancer	0.000296	0.0018	CcSEcCtD
Buspirone—Body temperature increased—Methotrexate—esophageal cancer	0.000294	0.00179	CcSEcCtD
Buspirone—Hypersensitivity—Methotrexate—esophageal cancer	0.000274	0.00167	CcSEcCtD
Buspirone—Asthenia—Methotrexate—esophageal cancer	0.000267	0.00162	CcSEcCtD
Buspirone—Pruritus—Methotrexate—esophageal cancer	0.000263	0.0016	CcSEcCtD
Buspirone—Diarrhoea—Methotrexate—esophageal cancer	0.000255	0.00155	CcSEcCtD
Buspirone—Dizziness—Methotrexate—esophageal cancer	0.000246	0.00149	CcSEcCtD
Buspirone—Vomiting—Methotrexate—esophageal cancer	0.000237	0.00144	CcSEcCtD
Buspirone—Rash—Methotrexate—esophageal cancer	0.000235	0.00143	CcSEcCtD
Buspirone—Dermatitis—Methotrexate—esophageal cancer	0.000234	0.00142	CcSEcCtD
Buspirone—Headache—Methotrexate—esophageal cancer	0.000233	0.00142	CcSEcCtD
Buspirone—Nausea—Methotrexate—esophageal cancer	0.000221	0.00134	CcSEcCtD
Buspirone—HTR2A—Signaling Pathways—HIST1H2BM—esophageal cancer	4.94e-05	0.000326	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SST—esophageal cancer	4.93e-05	0.000326	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GAPDH—esophageal cancer	4.93e-05	0.000325	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PDE4D—esophageal cancer	4.9e-05	0.000324	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CRABP1—esophageal cancer	4.88e-05	0.000323	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NOTCH3—esophageal cancer	4.8e-05	0.000317	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—GHRL—esophageal cancer	4.8e-05	0.000317	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CTNNA1—esophageal cancer	4.78e-05	0.000316	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CXCL2—esophageal cancer	4.75e-05	0.000314	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GNG7—esophageal cancer	4.73e-05	0.000313	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—FBXW7—esophageal cancer	4.73e-05	0.000312	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ADH1B—esophageal cancer	4.66e-05	0.000308	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GNG7—esophageal cancer	4.66e-05	0.000308	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GNG7—esophageal cancer	4.64e-05	0.000307	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NOTCH2—esophageal cancer	4.63e-05	0.000306	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CYP1B1—esophageal cancer	4.56e-05	0.000301	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.56e-05	0.000301	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.53e-05	0.000299	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.53e-05	0.000299	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—TYMP—esophageal cancer	4.45e-05	0.000294	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PSME2—esophageal cancer	4.44e-05	0.000293	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PSME1—esophageal cancer	4.44e-05	0.000293	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—XIAP—esophageal cancer	4.44e-05	0.000293	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ANXA1—esophageal cancer	4.42e-05	0.000292	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ADH1B—esophageal cancer	4.39e-05	0.00029	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.37e-05	0.000289	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—XIAP—esophageal cancer	4.36e-05	0.000288	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ALDH2—esophageal cancer	4.35e-05	0.000288	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.33e-05	0.000286	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NOTCH2—esophageal cancer	4.31e-05	0.000285	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SST—esophageal cancer	4.3e-05	0.000284	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CYP19A1—esophageal cancer	4.29e-05	0.000283	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.28e-05	0.000282	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ALOX15—esophageal cancer	4.22e-05	0.000279	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—TYMP—esophageal cancer	4.2e-05	0.000277	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CTNNA1—esophageal cancer	4.19e-05	0.000277	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—GHRL—esophageal cancer	4.19e-05	0.000277	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NOTCH3—esophageal cancer	4.19e-05	0.000277	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CXCL2—esophageal cancer	4.17e-05	0.000276	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GSTT1—esophageal cancer	4.14e-05	0.000273	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CTNNA1—esophageal cancer	4.13e-05	0.000273	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—FBXW7—esophageal cancer	4.12e-05	0.000272	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TGFBR2—esophageal cancer	4.11e-05	0.000271	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CXCL2—esophageal cancer	4.1e-05	0.000271	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CYP2A6—esophageal cancer	4.09e-05	0.00027	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	4.08e-05	0.00027	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GSTO1—esophageal cancer	4.03e-05	0.000266	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—TPI1—esophageal cancer	4.03e-05	0.000266	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.98e-05	0.000263	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—HMOX1—esophageal cancer	3.91e-05	0.000259	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PSME1—esophageal cancer	3.9e-05	0.000257	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PSME2—esophageal cancer	3.9e-05	0.000257	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SMAD4—esophageal cancer	3.89e-05	0.000257	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ENO1—esophageal cancer	3.88e-05	0.000256	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS1—esophageal cancer	3.88e-05	0.000256	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ANXA1—esophageal cancer	3.88e-05	0.000256	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ALDOB—esophageal cancer	3.86e-05	0.000255	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CA1—esophageal cancer	3.85e-05	0.000254	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.85e-05	0.000254	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PSME1—esophageal cancer	3.83e-05	0.000253	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PSME2—esophageal cancer	3.83e-05	0.000253	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PSME1—esophageal cancer	3.82e-05	0.000253	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PSME2—esophageal cancer	3.82e-05	0.000253	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TGFBR2—esophageal cancer	3.82e-05	0.000253	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ANXA1—esophageal cancer	3.81e-05	0.000252	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—TPI1—esophageal cancer	3.8e-05	0.000251	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.8e-05	0.000251	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SST—esophageal cancer	3.77e-05	0.000249	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—ABCB1—esophageal cancer	3.76e-05	0.000248	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NOTCH2—esophageal cancer	3.75e-05	0.000248	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GAPDH—esophageal cancer	3.72e-05	0.000246	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SST—esophageal cancer	3.71e-05	0.000245	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.71e-05	0.000245	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CRABP1—esophageal cancer	3.68e-05	0.000243	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GHRL—esophageal cancer	3.68e-05	0.000243	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NOTCH3—esophageal cancer	3.68e-05	0.000243	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.64e-05	0.00024	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SMAD4—esophageal cancer	3.62e-05	0.000239	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GHRL—esophageal cancer	3.62e-05	0.000239	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOTCH3—esophageal cancer	3.62e-05	0.000239	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—FBXW7—esophageal cancer	3.62e-05	0.000239	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.59e-05	0.000237	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—FBXW7—esophageal cancer	3.56e-05	0.000235	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CA2—esophageal cancer	3.52e-05	0.000233	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GNG7—esophageal cancer	3.5e-05	0.000232	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.5e-05	0.000231	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.47e-05	0.000229	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TGFBR2—esophageal cancer	3.33e-05	0.00022	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GNG7—esophageal cancer	3.3e-05	0.000218	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CYP1B1—esophageal cancer	3.3e-05	0.000218	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NOTCH2—esophageal cancer	3.3e-05	0.000218	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ALDH2—esophageal cancer	3.28e-05	0.000217	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.27e-05	0.000216	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ADH7—esophageal cancer	3.27e-05	0.000216	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOTCH2—esophageal cancer	3.24e-05	0.000214	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HIF1A—esophageal cancer	3.18e-05	0.00021	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SMAD4—esophageal cancer	3.15e-05	0.000208	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GSTT1—esophageal cancer	3.12e-05	0.000206	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CYP19A1—esophageal cancer	3.1e-05	0.000205	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ALDH2—esophageal cancer	3.09e-05	0.000204	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.09e-05	0.000204	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—KDR—esophageal cancer	3.04e-05	0.000201	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HIF1A—esophageal cancer	2.96e-05	0.000196	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.94e-05	0.000194	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ENO1—esophageal cancer	2.93e-05	0.000193	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS1—esophageal cancer	2.93e-05	0.000193	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TGFBR2—esophageal cancer	2.92e-05	0.000193	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.92e-05	0.000193	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.91e-05	0.000192	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PSME1—esophageal cancer	2.88e-05	0.000191	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PSME2—esophageal cancer	2.88e-05	0.000191	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TGFBR2—esophageal cancer	2.88e-05	0.00019	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.87e-05	0.00019	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NOTCH1—esophageal cancer	2.87e-05	0.000189	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KDR—esophageal cancer	2.83e-05	0.000187	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.83e-05	0.000187	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SMAD4—esophageal cancer	2.77e-05	0.000183	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ENO1—esophageal cancer	2.76e-05	0.000182	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.76e-05	0.000182	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TYMP—esophageal cancer	2.74e-05	0.000181	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SMAD4—esophageal cancer	2.72e-05	0.00018	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PSME2—esophageal cancer	2.72e-05	0.00018	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PSME1—esophageal cancer	2.72e-05	0.00018	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.72e-05	0.000179	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.67e-05	0.000176	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NOTCH1—esophageal cancer	2.67e-05	0.000176	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.6e-05	0.000172	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CREBBP—esophageal cancer	2.6e-05	0.000172	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	2.58e-05	0.00017	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—EGFR—esophageal cancer	2.55e-05	0.000169	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.51e-05	0.000166	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.49e-05	0.000164	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TPI1—esophageal cancer	2.48e-05	0.000164	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.48e-05	0.000164	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KDR—esophageal cancer	2.47e-05	0.000163	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—PIK3CA—esophageal cancer	2.44e-05	0.000161	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CREBBP—esophageal cancer	2.42e-05	0.00016	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.38e-05	0.000157	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—EGFR—esophageal cancer	2.38e-05	0.000157	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.35e-05	0.000155	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.34e-05	0.000155	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NOS3—esophageal cancer	2.33e-05	0.000154	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	2.32e-05	0.000154	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.29e-05	0.000151	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—PIK3CA—esophageal cancer	2.27e-05	0.00015	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.27e-05	0.00015	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HIF1A—esophageal cancer	2.27e-05	0.00015	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—NOS3—esophageal cancer	2.25e-05	0.000149	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HIF1A—esophageal cancer	2.23e-05	0.000147	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—PIK3CA—esophageal cancer	2.22e-05	0.000146	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.2e-05	0.000146	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ERBB2—esophageal cancer	2.18e-05	0.000144	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KDR—esophageal cancer	2.17e-05	0.000143	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NOS3—esophageal cancer	2.16e-05	0.000143	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GNG7—esophageal cancer	2.16e-05	0.000143	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—HMOX1—esophageal cancer	2.14e-05	0.000141	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KDR—esophageal cancer	2.13e-05	0.000141	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	2.11e-05	0.000139	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	2.07e-05	0.000137	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—PIK3CA—esophageal cancer	2.06e-05	0.000136	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.06e-05	0.000136	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NOTCH1—esophageal cancer	2.04e-05	0.000135	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ERBB2—esophageal cancer	2.02e-05	0.000134	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.02e-05	0.000134	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.01e-05	0.000133	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOTCH1—esophageal cancer	2.01e-05	0.000133	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.98e-05	0.000131	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.93e-05	0.000128	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.92e-05	0.000127	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CCND1—esophageal cancer	1.92e-05	0.000127	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.9e-05	0.000126	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NOS3—esophageal cancer	1.89e-05	0.000125	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CDKN1A—esophageal cancer	1.86e-05	0.000123	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CREBBP—esophageal cancer	1.85e-05	0.000122	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CREBBP—esophageal cancer	1.82e-05	0.00012	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—EGFR—esophageal cancer	1.82e-05	0.00012	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.82e-05	0.00012	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ENO1—esophageal cancer	1.8e-05	0.000119	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.8e-05	0.000119	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	1.8e-05	0.000119	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCND1—esophageal cancer	1.79e-05	0.000118	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	1.79e-05	0.000118	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PSME2—esophageal cancer	1.78e-05	0.000117	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PSME1—esophageal cancer	1.78e-05	0.000117	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EP300—esophageal cancer	1.77e-05	0.000117	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	1.76e-05	0.000117	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.74e-05	0.000115	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1A—esophageal cancer	1.73e-05	0.000114	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—EP300—esophageal cancer	1.71e-05	0.000113	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.71e-05	0.000113	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NOS3—esophageal cancer	1.66e-05	0.000109	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EP300—esophageal cancer	1.65e-05	0.000109	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOS3—esophageal cancer	1.63e-05	0.000108	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—NOS3—esophageal cancer	1.63e-05	0.000107	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	1.58e-05	0.000104	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCND1—esophageal cancer	1.56e-05	0.000103	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	1.55e-05	0.000103	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ERBB2—esophageal cancer	1.55e-05	0.000102	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MYC—esophageal cancer	1.54e-05	0.000102	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.53e-05	0.000101	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	1.52e-05	0.000101	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGFR—esophageal cancer	1.51e-05	9.97e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	1.51e-05	9.97e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.49e-05	9.82e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.44e-05	9.52e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EP300—esophageal cancer	1.44e-05	9.48e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MYC—esophageal cancer	1.43e-05	9.48e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGFR—esophageal cancer	1.4e-05	9.27e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CREBBP—esophageal cancer	1.37e-05	9.05e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCND1—esophageal cancer	1.37e-05	9.04e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCND1—esophageal cancer	1.35e-05	8.9e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	1.32e-05	8.75e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.32e-05	8.69e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CA—esophageal cancer	1.31e-05	8.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	1.3e-05	8.61e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.29e-05	8.53e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—esophageal cancer	1.27e-05	8.37e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.27e-05	8.36e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.26e-05	8.34e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EP300—esophageal cancer	1.26e-05	8.33e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MYC—esophageal cancer	1.25e-05	8.26e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EP300—esophageal cancer	1.24e-05	8.19e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—EP300—esophageal cancer	1.24e-05	8.17e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NOS3—esophageal cancer	1.23e-05	8.1e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGFR—esophageal cancer	1.22e-05	8.08e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CA—esophageal cancer	1.22e-05	8.05e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—esophageal cancer	1.18e-05	7.79e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NOS3—esophageal cancer	1.16e-05	7.63e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—esophageal cancer	1.12e-05	7.41e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MYC—esophageal cancer	1.1e-05	7.25e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MYC—esophageal cancer	1.08e-05	7.14e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGFR—esophageal cancer	1.07e-05	7.1e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	1.06e-05	7.01e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.06e-05	6.98e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGFR—esophageal cancer	1.06e-05	6.98e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—esophageal cancer	1.03e-05	6.79e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—EP300—esophageal cancer	9.33e-06	6.16e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	9.32e-06	6.16e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	9.17e-06	6.06e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CA—esophageal cancer	9.14e-06	6.04e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—esophageal cancer	9.02e-06	5.96e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—esophageal cancer	8.87e-06	5.86e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—EP300—esophageal cancer	8.79e-06	5.81e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CREBBP—esophageal cancer	8.44e-06	5.58e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NOS3—esophageal cancer	7.56e-06	4.99e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.91e-06	4.57e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CA—esophageal cancer	6.9e-06	4.56e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	6.5e-06	4.3e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—EP300—esophageal cancer	5.75e-06	3.8e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.25e-06	2.81e-05	CbGpPWpGaD
